Search

everythinglearnresearchcommunity

for

Search:↓

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The method accurately measures the amount of ketoconazole in anti-dandruff shampoo and cream, and can also be used to monitor the drug in human plasma.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

Low dose valproic acid treatment caused hair loss in a young patient.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

The new microneedle system improves hair growth in alopecia treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

SOD1 and KL are promising targets for new hair loss treatments.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Quercetin-loaded nanogels show promise for treating alopecia effectively.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Computational methods can speed up and improve the development and safety of herbal drugs.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Finasteride helps treat hair loss by blocking enzyme activity.

The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.

Stopping azathioprine improved hair loss and bone marrow issues.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Macroalgae may help treat hair loss and could be used in new hair growth products.